Kerala Ayurveda

Kerala_Ayurveda03 May 2024

Pharmaceuticals

₹

-12.00 (-3.80%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Kerala Ayurveda

Kerala Ayurveda

Pharmaceuticals

Kerala_Ayurveda03 May 2024

₹

-12.00 (-3.80%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
23-Apr-2024	BC	Source: BSE Announcement PDF	23-Apr-2024
26-Mar-2024	BC	Trading members of the Exchange are hereby informed that the under mentioned new securities of Kerala Ayurveda Limited (Scrip Code - 530163) are listed and permitted to trade on the Exchange with eff	27-Mar-2024
06-Feb-2024	BC	KERALA AYURVEDA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve the unaudited financial results for the qu	14-Feb-2024
24-Nov-2023	BC	Outcome of the Board meeting held on 24/11/2023 EGM on 20th December, 2023 (As Per BSE Announcement dated on 28.11.2023) Addendum to EGM Notice News paper publications (As per BSE Anno	20-Dec-2023
24-Nov-2023	BC	Trading members of the Exchange are hereby informed that the under mentioned new securities of Kerala Ayurveda Limited (Scrip Code - 530163) are listed and permitted to trade on the Exchange with ef	28-Nov-2023

No Rights has been declared by Kerala_Ayurveda

Book Closure

Record Date	Split Date	Purpose
23-Apr-2024	01 Jan'1900	Source: BSE Announcement PDF
27-Mar-2024	-	Trading members of the Exchange are hereby informed that the under mentioned new securities of Kerala Ayurveda Limited (Scrip Code - 530163) are listed and permitted to trade on the Exchange with eff
14-Feb-2024	-	KERALA AYURVEDA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve the unaudited financial results for the qu
20-Dec-2023	-	Outcome of the Board meeting held on 24/11/2023 EGM on 20th December, 2023 (As Per BSE Announcement dated on 28.11.2023) Addendum to EGM Notice News paper publications (As per BSE Anno
28-Nov-2023	-	Trading members of the Exchange are hereby informed that the under mentioned new securities of Kerala Ayurveda Limited (Scrip Code - 530163) are listed and permitted to trade on the Exchange with ef

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Kerala Ayurveda Ltd ₹303.75(-12.00/-3.80%)	303.75	-12.00	365.49	196.34	0.00	8.39
Astrazeneca Pharma India Ltd ₹5,424.45(+90.60/1.70%)	5,424.45	+90.60	13,561.13	71.45	85.02	20.71
Bliss GVS Pharma Ltd ₹119.10(-10.10/-7.82%)	119.10	-10.10	1,246.87	56.07	18.27	1.28
Cipla Ltd ₹1,424.75(+5.20/0.37%)	1,424.75	+5.20	115,033.60	54.70	34.98	4.44
Amrutanjan Health Care Ltd ₹775.50(-11.10/-1.41%)	775.50	-11.10	2,242.02	27.78	50.95	8.56
Abbott India Ltd ₹26,144.45(-459.90/-1.73%)	26,144.45	-459.90	55,556.96	15.92	48.50	17.87

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	17.28	18.75	17.00	15.96	15.27	16.82
Excise Duty	0.00	0.00	0.00	0.95	0.00	0.00
Net Sales	17.28	18.75	17.00	15.01	15.27	16.82
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.08	0.74	0.06	0.10	2.89	0.21
Total Income	17.36	19.48	17.06	15.11	18.15	17.03
Total Expenditure	16.81	18.18	15.20	14.43	14.80	14.73
PBIDT	0.55	1.31	1.86	0.68	3.36	2.29
Interest	0.48	0.45	1.40	1.16	1.07	1.04
PBDT	0.07	0.86	0.47	-0.48	2.29	1.25
Depreciation	0.19	0.18	0.19	0.12	0.18	0.17
Tax	0.14	0.17	0.07	-1.27	0.53	0.27
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	-0.27	0.51	0.21	0.67	1.58	0.81
Extra-ordinary Items	0.00	0.40	0.00	0.00	2.30	0.00
Adjusted Profit After Extra-ordinary item	-0.27	0.11	0.21	0.67	-0.72	0.81

EPS (Unit Curr.)	-0.18	1.05	0.26	2.00	1.74	0.78
EPS (Adj) (Unit Curr.)	-0.18	1.05	0.26	2.00	1.74	0.78
Calculated EPS (Unit Curr.)	-0.24	0.48	0.19	0.63	1.50	0.77
Calculated EPS (Adj) (Unit Curr.)	-0.24	0.48	0.19	0.63	1.50	0.77
Calculated EPS (Ann.) (Unit Curr.)	-0.97	1.93	0.78	2.52	5.99	3.06
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-0.97	1.93	0.78	2.52	5.99	3.06
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	11.11	10.56	10.56	10.56	10.56	10.56
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	3.18	6.99	10.94	4.53	22.00	13.61
PBDTM(%)	0.41	4.59	2.76	-3.20	15.00	7.43
PATM(%)	-1.56	2.72	1.24	4.46	10.35	4.82

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	26.32	26.17	24.91	24.71	23.33	23.95
Excise Duty	0.00	0.00	0.00	0.95	0.00	0.00
Net Sales	26.32	26.17	24.91	23.76	23.33	23.95
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.23	0.77	0.16	0.19	2.93	0.27
Total Income	26.54	26.94	25.07	23.95	26.26	24.22
Total Expenditure	25.31	25.63	23.38	23.15	24.93	21.74
PBIDT	1.23	1.31	1.69	0.80	1.33	2.48
Interest	0.61	0.65	1.51	1.25	1.33	1.05
PBDT	0.63	0.66	0.18	-0.45	0.00	1.43
Depreciation	0.34	0.32	0.33	0.23	0.29	0.26
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	1.07	0.34	0.16	-1.16	0.81	0.15
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	-0.79	0.00	-0.30	0.47	-1.10	1.02
Minority Interest After NP	-0.07	0.13	0.06	0.29	0.12	-0.02
Net Profit after Minority Interest	-0.72	-0.13	-0.36	0.18	-1.22	1.03

Extra-ordinary Items	0.00	0.19	0.00	0.00	2.03	0.00
Adjusted Profit After Extra-ordinary item	-0.72	-0.32	-0.36	0.18	-3.25	1.03

EPS (Unit Curr.)	-0.65	-0.12	-0.34	0.24	-0.91	0.98
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	10.56	10.56	10.56	10.56	10.56	10.56

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	4.67	5.01	6.78	3.37	5.70	10.35
PBDTM(%)	2.39	2.52	0.72	-1.89	0.00	5.97
PATM(%)	-3.00	0.00	-1.20	1.98	-4.71	4.26

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	10.56	10.56	10.56	10.56	10.56	10.56
Reserves Total	3.98	0.72	-0.51	4.11	2.94	7.12
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	14.54	11.28	10.05	14.67	13.50	17.68
Secured Loans	22.02	32.63	10.59	10.64	11.25	30.91
Unsecured Loans	40.43	28.76	55.43	47.16	45.04	38.68
Total Debt	62.45	61.39	66.02	57.80	56.29	69.59
Total Liabilities	76.99	72.67	76.07	72.47	69.79	87.27
APPLICATION OF FUNDS :
Gross Block	43.60	40.86	38.44	28.43	27.28	26.68
Less : Accumulated Depreciation	13.28	12.90	12.00	11.33	10.65	10.19
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	30.32	27.96	26.44	17.10	16.63	16.49
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	2.34	2.34	11.55	9.94	8.65
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	11.37	11.37	11.37	11.47	11.47	11.47
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	9.68	9.38	9.50	11.46	10.75	9.96
Sundry Debtors	12.07	10.36	9.77	9.07	8.82	7.17
Cash and Bank	0.55	0.13	1.07	1.90	0.84	4.34
Loans and Advances	2.50	3.52	7.45	4.94	7.03	21.25
Total Current Assets	24.79	23.39	27.80	27.38	27.44	42.72
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	14.87	13.86	10.85	10.71	7.65	6.92
Provisions	1.03	0.64	0.77	0.94	0.89	1.38
Total Current Liabilities	15.90	14.50	11.62	11.65	8.55	8.30
Net Current Assets	8.89	8.89	16.18	15.73	18.89	34.42
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.89	0.37	1.22	0.00	0.38	0.22
Deferred Tax Liability	0.00	0.00	0.50	0.91	0.95	0.88
Net Deferred Tax	0.89	0.37	0.72	-0.91	-0.57	-0.66
Total Assets	51.47	50.94	57.05	54.93	56.35	70.37
Contingent Liabilities	0.00	0.00	0.00	0.00	0.05	0.00

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	10.56	10.56	10.56	10.56	10.56	10.56
Reserves Total	-4.98	-4.45	-7.15	-2.63	-6.83	-2.65
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	5.58	6.11	3.41	7.93	3.73	7.91
Minority Interest	2.30	1.83	1.80	1.80	1.64	1.57
Secured Loans	12.19	7.00	10.61	10.67	11.26	17.57
Unsecured Loans	60.25	62.94	66.08	53.49	50.51	57.57
Total Debt	72.44	69.94	76.69	64.16	61.77	75.14
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	4.91	4.80	8.86	8.92	8.55	4.00
Total Liabilities	85.23	82.68	90.76	82.81	75.69	88.62
APPLICATION OF FUNDS :
Gross Block	70.14	67.22	54.56	53.94	52.16	51.19
Less: Accumulated Depreciation	23.72	23.19	21.81	20.53	19.34	18.74
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	46.42	44.03	32.75	33.41	32.82	32.45
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	6.84	4.46	14.09	13.66	12.05	10.96
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.03	0.03	0.03	0.13	0.13	0.13
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	12.49	11.97	11.00	12.83	11.58	10.45
Sundry Debtors	12.96	13.34	10.33	10.71	6.90	5.44
Cash and Bank	3.20	2.87	18.56	6.37	4.55	6.72
Loans and Advances	5.42	8.96	3.76	3.06	5.26	19.42
Total Current Assets	34.07	37.15	43.65	32.97	28.29	42.03
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	28.06	27.00	22.96	17.69	14.55	11.39
Provisions	1.43	0.64	0.77	1.17	1.03	1.72
Total Current Liabilities	29.49	27.64	23.73	18.87	15.58	13.11
Net Current Assets	4.58	9.51	19.92	14.10	12.70	28.92
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.70	0.20	0.61	0.00	0.46	0.29
Deferred Tax Liability	0.00	0.00	0.00	1.29	1.48	1.50
Net Deferred Tax	0.70	0.20	0.61	-1.29	-1.02	-1.21
Other Assets	26.65	24.45	23.36	22.80	19.00	17.36
Total Assets
Contingent Liabilities	0.00	0.00	0.00	0.00	0.05	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.13	1.07	1.90	0.84	4.34
Net Cash from Operating Activities	9.12	8.75	-0.91	4.71	9.34
Net Cash Used In Investing Activities	-5.32	0.83	-2.10	-3.93	-1.70
Net Cash Used In Financing Activities	-3.38	-10.52	2.18	0.29	-11.14
Net Inc./Dec In Cash And Cash Equivalents	0.41	-0.94	-0.83	1.06	-3.50
Cash And Cash Equivalents At End Of The Year	0.55	0.13	1.07	1.90	0.84

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

58.58%

FII Shareholding

0.00%

DII Shareholding

0.04%

Public Shareholding

41.38%

**Promoter pledged shareholding 58.58%

About Kerala Ayurveda Ltd

Kerala Ayurveda Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 365.49 crores. It has reported a sales of Rs. 17.28 crores and a net profit of Rs. -0.27 crores for the quarter ended December 2018. The company management includes Ramesh Vangal, Ramesh Vangal,K Anilkumar,Anand Subramanian,Harish Menon,Gokul Patnaik,S Krishnamurthy,Shilpa Kiran Gududur,Rajesh Sharma,Jyothi Gulecha (Kerala Ayurveda Ltd) among others.

Chairman

Ramesh Vangal

Registered office

VII/415 Nedumbassery,Athani P O Aluva,Ernakulam,Kerala,683585

FAX :91-484-2474376

Background

Incorporation Year1992

Face Value₹10

Market Lot1

How to buy Kerala Ayurveda shares on nse?

To buy Kerala Ayurveda shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Kerala Ayurveda share price today?

The Kerala Ayurveda shares price on nse is Rs.303.75 today.

What is the market cap of Kerala Ayurveda shares on BSE ?

The company has a market capitalization of Rs.365.49Cr

What is the PE & PB ratio of Kerala Ayurveda shares ?

PE is 0 and PB is 8.39

What is the 52 Week High and Low of Kerala Ayurveda shares?

Kerala Ayurveda stock price high: Rs.346.6 Kerala Ayurveda stock price low: Rs.98.05